Information  X 
Enter a valid email address

PureTech Health PLC (PRTC)

  Print      Mail a friend

Wednesday 19 August, 2015

PureTech Health PLC

Notice of Half-Yearly Results

RNS Number : 4993W
PureTech Health PLC
19 August 2015

19 August 2015


PureTech Health plc


Notice of Half-Yearly Results


PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a science-driven healthcare company seeking to solve some of the toughest health challenges in disruptive ways, expects to announce its half-yearly results for the six months ended 30 June 2015 at at 7.00am BST on Tuesday 25 August 2015.






Daphne Zohar, Chief Executive Officer

Stephen Muniz, Executive Vice President, Legal, Finance and Operations

Julie DiCarlo, Senior Vice President, Communications and Investor Relations


+1 617 456 0032

FTI Consulting (Communications adviser to PureTech)

Ben Atwell

Matthew Cole

Rob Winder

Natalie Garland-Collins

+44 (0) 20 3727 1000


About PureTech


PureTech (PureTech Health plc, PRTC.L) is a science-driven healthcare company, seeking to solve some of today's toughest health challenges through disruptive approaches. Based in Boston, Massachusetts, PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concept or peer review in prestigious scientific journals. PureTech is problem-focused and solution-agnostic, looking beyond traditional disciplines and approaching healthcare problems from different perspectives. Focusing on areas of significant unmet medical need, PureTech evaluates more than 650 ideas per year, prioritizing, selecting and testing what it believes to be the most scientifically and commercially promising concepts to advance. PureTech's leading team and board, along with an advisory network of more than 50 experts across multiple disciplines, gives PureTech access to potentially groundbreaking science and technological innovations. For more information, visit and connect with us on Twitter.


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t